Biognosys Portfolio – Transformative Insights from Discovery to Clinic
This comprehensive brochure provides an overview of our services, software, and kits offering.
This comprehensive brochure provides an overview of our services, software, and kits offering.
The brochure provides you with an overview of the key features and benefits which make Spectronaut the gold-standard software for DIA proteomics analysis. The brochure elaborates on Spectronaut’s easy library generation, high performance, reliability at scale, and all-in-one user experience.
The novel particle-based P2 Plasma Enrichment System achieves the highest reported proteome enrichment with greater reproducibility than any other protein corona-based workflow. The optimized single-well sample preparation, combined with optimized particle surface, stabilizes the labile protein corona and provides exceptional quantitative accuracy.
In this White Paper, we walk through the two main strategies for collecting and analyzing mass spectrometry data for discovery proteomics using a label-free quantification (LFQ) approach: data-dependent and data-independent acquisition-based strategies. We discuss the advantages of each in different situations to help you apply the right method for your needs.
The brochure provides you with an overview of the key features and benefits which make SpectroDive a fast, robust, and seamless solution for targeted proteomics. The brochure elaborates on how SpectroDive enables high-throughput analysis, provides deeper insights into human plasma, and aids integrated panel optimization and biological interpretation.
The brochure provides you with an overview of the key features and benefits which make SpectroMine the most powerful and user-friendly solution for DDA proteomics. The brochure elaborates on SpectroMine’s effortless isobaric labeling quantification, powerful search engine, and all-in-one workflow.
The brochure demonstrates how QuiC provides users with a powerful tool to improve the performance of their mass-spectrometric facility in combination with Biognosys’ indexed Retention Time (iRT) kit. Further, the brochure includes information on how to access QuiC free of charge.
The brochure provides you with an overview of the main features and benefits which make PQ500 the key to the plasma proteome. The brochure elaborates on its accuracy, coverage and depth, as well as different application types. Finally, ordering and customer support information is provided.
The brochure provides an overview of the key features and benefits of our next-generation TrueDiscovery™ platform. In addition, it elaborates on our deep and reproducible proteome, phospho- and immune-proteome quantification and analysis. Finally, it digs into how we identify the most promising and actionable biomarkers for research and clinical decision-making.
The brochure provides an overview of the key features and benefits of our next-generation TrueSignature® platform. In addition, it elaborates on the specificities of our customizable panels for clinical and pharmacodynamics studies.
Harnessing the information present in the plasma proteome requires robust large-scale analytical techniques. Our latest white paper gives you a better understanding of two leading technology platforms for Plasma Proteomics: Biognosys’ TrueDiscovery™ and Olink Explore.
In this white paper, we explain how advances in mass spectrometry can now unlock the potential of the plasma proteome, uncovering actionable insights essential for biomarker discovery and targeted drug development.
Learn more about Biognosys’ proprietary TrueTarget™ platform in our latest brochure. This resource elaborates on how TrueTarget™ identifies the most promising and actionable drug targets to support your research.
Biognosys AG
Wagistrasse 21
8952 Schlieren
Switzerland
Phone: +41 44 738 20 40
US Offices
Biognosys Inc
70 Bridge St, Suite 104
Newton, MA 02458
United States
